DigiTx Partners, a digital health investment firm, recently resulted from a three-way partnership between San Francisco’s DigiTx Partners LLC , Tokyo-based Astellas Pharma Inc. and Boston-based MPM Capital Inc.
The DigiTx Partners parent organization’s CEO David Kim will spearhead the new entity. With a medical degree from Johns Hopkins University and an MBA from Stanford, he brings extensive investment and operational experience in health care and digital business.
“In the digital health space, there is no shortage of innovative technologies and companies that would markedly improve health care and the effective delivery of this care to the community,” Kim said. “DigiTx Partners aims to identify and foster those companies that will meaningfully contribute to this improvement. From day one, it will be able to leverage the considerable resources of both Astellas and MPM Capital to execute on this goal.”
Astellas’ SVP and chief strategy officer Kenji Yasukawa outlined the team’s “creating innovation” approach as part of his company’s strategic plan.
“Through the investment activities of DigiTx Partners, we will explore the business opportunities in the growing field of digital health and extend our knowledge in the area,” Yasukawa said. “We look forward to supporting those companies with technologies that will deliver innovative solutions impacting patients’ health care and wellness.”
Astellas focuses on pharmaceutical solutions for urology, oncology, immunology, nephrology and neuroscience; MPM Capital is an early-stage life science investment firm.